| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;91:2948-2954.)
© 1995 American Heart Association, Inc.
Articles |
Use of Intravascular Stents in Systemic Venous and Systemic Venous Baffle Obstructions
Short-term Follow-up Results
From the Lillie Frank Abercrombie Section of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Tex.
Background Balloon-expandable intravascular stents are well accepted in the management of arterial obstructions. This study was undertaken to detail the immediate and short-term results of intravascular stent implantation in systemic venous and systemic venous baffle obstructions in children.
Methods and Results Between September 1991 and June 1994, 12 patients had 21 stents implanted in 13 systemic venous obstructions, 1 patient having stents placed in 2 separate obstructions. In the baffle group, 4 of 13 obstructions were at the superior vena cava/right atrial junction after atrial baffling for transposition of the great arteries. One of 4 patients had complete obstruction requiring transseptal needle perforation before stent implantation. There was an immediate gradient reduction from 12±8.4 mm Hg (range, 4 to 20 mm Hg) to 1.3±1.9 mm Hg (range, 0 to 4 mm Hg, P=.05). The obstructed segment diameter increased from 3.5±3.9 mm (range, 0 to 8.5 mm) to 16±2.7 mm (range, 14 to 20 mm, P=.002). In the central vein group, 9 of 13 obstructions were in large central veins. Three of 9 patients had complete obstruction requiring transseptal needle perforation before stent implantation. There was an immediate gradient reduction from 10.3±8.5 mm Hg (range, 0 to 20 mm Hg) to 0.8±1.1 mm Hg (range, 0 to 3 mm Hg, P=.005). The obstructed segment diameter increased from 1.3±1.1 mm (range, 0 to 2.8 mm) to 9.4±1.7 mm (range, 7.6 to 12 mm, P<.001). There were no acute complications in either group. In the follow-up group, patients were scheduled for clinical follow-up at 3, 6, and 12 months with echocardiography or magnetic resonance imaging (MRI) at 3 or 6 months and for repeat cardiac catheterization at 12 months. All stents were patent by echocardiography or MRI when studied at follow-up. Cardiac catheterization in 6 of 12 patients, 2 to 13 months after stent, demonstrated that all stents remained patent without compression or fracture. Follow-up and immediate poststent gradients were not significantly different (1±1.6 versus 0.7±1.2 mm Hg, P=NS). Neointimal hyperplasia (5 of 6 patients) reduced the stent lumen only from 12.5±4.7 mm (range, 8 to 20 mm) to 10.6±4.7 mm (range, 4.5 to 17.7 mm, P=NS). No stents required redilation. One of 18 stents placed in series had "unlocked" and rotated in the venous lumen but remained fully patent to flow.
Conclusions Balloon-expandable intravascular stents can be safely and effectively used to relieve systemic venous and systemic venous baffle obstructions, even when obstruction is complete. Short-term follow-up suggests excellent continued patency, but further follow-up is required to observe for progression of neointimal hyperplasia. We postulate that balloon-expandable intravascular stents will become the treatment of choice for the relief of selected systemic venous and venous baffle obstructions in the pediatric population.
Key Words: stents • veins • heart defects, congenital
This article has been cited by other articles:
 |
|
 |
|
  R. J. Sommer, Z. M. Hijazi, and J. F. Rhodes Pathophysiology of Congenital Heart Disease in the Adult: Part III: Complex Congenital Heart Disease Circulation, March 11, 2008; 117(10): 1340 - 1350. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Amir, A. Khoury, A. Lorber, and D. Mishaly Extracardiac reconstruction of anomalous superior systemic venous return Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 328 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Peuster, P Wohlsein, M Brugmann, M Ehlerding, K Seidler, C Fink, H Brauer, A Fischer, and G Hausdorf A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal---results 6-18 months after implantation into New Zealand white rabbits Heart, November 1, 2001; 86(5): 563 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. McMahon, H. G. El-Said, R. G. Grifka, J. K. Fraley, M. R. Nihill, and C. E. Mullins Redilation of endovascular stents in congenital heart disease: factors implicated in the development of restenosis and neointimal proliferation J. Am. Coll. Cardiol., August 1, 2001; 38(2): 521 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. F. Ing, T. E. Fagan, R. G. Grifka, S. Clapp, M. R. Nihill, M. Cocalis, J. Perry, J. Mathewson, and C. E. Mullins Reconstruction of stenotic or occluded iliofemoral veins and inferior vena cava using intravascular stents: re-establishing access for future cardiac catheterization and cardiac surgery J. Am. Coll. Cardiol., January 1, 2001; 37(1): 251 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bull, R Yates, D Sarkar, J Deanfield, and M de Leval Scientific, ethical, and logistical considerations in introducing a new operation: a retrospective cohort study from paediatric cardiac surgery BMJ, April 29, 2000; 320(7243): 1168 - 1173. [Abstract] [Full Text]
|
|
|
|
|
|
T. Miura, T. Sano, and H. Matsuda Intravascular stenting of systemic venous baffle stenosis after corrective surgery for double outlet right ventricle with left isomerism Heart, February 1, 1999; 81(2): 218 - 220. [Abstract] [Full Text]
|
|
|
|
|
|
E ROSENTHAL and S A QURESHI Stenting of systemic venous pathways after atrial repair for complete transposition Heart, March 1, 1998; 79(3): 211 - 212. [Full Text]
|
|
|
|
|
|
F A Bu'Lock, A J P Tometzki, D J Kitchiner, R Arnold, I Peart, and K P Walsh Balloon expandable stents for systemic venous pathway stenosis late after Mustard's operation Heart, March 1, 1998; 79(3): 225 - 229. [Abstract] [Full Text]
|
|
|
|
|
|
S C Brown, B Eyskens, L Mertens, L Stockx, M Dumoulin, and M Gewillig Self expandable stents for relief of venous baffle obstruction after the Mustard operation Heart, March 1, 1998; 79(3): 230 - 233. [Abstract] [Full Text]
|
|
|
|
|
|
H. D. Allen, R. H. Beekman III, A. Garson Jr, Z. M. Hijazi, C. Mullins, M. P. O'Laughlin, and K. A. Taubert Pediatric Therapeutic Cardiac Catheterization : A Statement for Healthcare Professionals From the Council on Cardiovascular Disease in the Young, American Heart Association Circulation, February 17, 1998; 97(6): 609 - 625. [Full Text] [PDF]
|
|